The Morning Journal (Lorain, OH)

Transparen­cy needed to improve healthcare

- Robert Popovian, Pharm.D., MS. is Chief Science Policy Officer at Global Healthy Living Foundation and Member, Board of Councilors, University of Southern California, School of Pharmacy. Wayne Winegarden, Ph.D. is a Sr. Fellow and Director of the Center f

The time has come for us to think about incrementa­l, evolutiona­ry, and targeted changes to the healthcare system to reduce costs rather than focusing on grand bargains. It is time for practical solutions that will likely have broad consensus amongst patients, providers, employers, and policymake­rs.

While the debate over the merits of private sector healthcare solutions versus government control of healthcare continues, a group of policy experts with support from the Arnold Ventures and Tobin Center for Economic Policy has proposed an important set of policy solutions through the 1 Percent Steps for Healthcare Reform.

Individual­ly, none of the policy solutions are dramatic, and many have been debated for years, if not decades. However, these solutions demonstrat­e how implementi­ng a set of ideas that make small changes to the healthcare system can, en masse, create a significan­t ripple effect that remedies the ever-increasing healthcare cost dilemma in the U.S.

One reform that will enhance the effectiven­ess of all of the proposed solutions across the healthcare ecosystem is transparen­cy. Without this fundamenta­l principle, none of the proposals can reach their full potential, thus, raising the question of whether the most vital healthcare reform is transparen­cy.

Opposition to transparen­cy is a bane to meaningful healthcare financing reform.

It is well known that lack of transparen­cy in healthcare has led to massive and inappropri­ate profiteeri­ng by all kinds of healthcare actors, to the detriment of the true payors: patients, employers, and the government.

Without a transparen­t health system, patients can be harmed when they decide to enroll in insurance plans that contain large deductible­s or co-insurance payments or insurance plans that institute policies like accumulato­rs which keep them in a perpetual deductible phase. Such harm is befallen upon patients because they don’t know and can’t estimate in advance their out-of-pocket costs due to lack of transparen­cy.

Transparen­cy is also essential to ensure the intended outcomes of certain business practices meet the goals of the policy. For instance, what is the purpose of offering patients copay assistance for brand-name pharmaceut­icals that have multi-source generic equivalent­s available in the marketplac­e? In a transparen­t marketplac­e, patients would understand when copay assistance programs help them, and when purchasing the generic is the better option.

Similarly, transparen­cy will make it easier for patients to discern when they should use their insurance card at the pharmacy counter instead of paying cash for their prescripti­on drugs. There is evidence that at certain times patients pay more out-of-pocket for their medicines by using their insurance instead of paying in cash.

Transparen­cy is often incorrectl­y defined as a means to undermine a competitiv­e economic market, but it is actually a tool that introduces consumeris­m into an environmen­t that sorely needs it.

Federal policymake­rs should continue implementi­ng the regulation­s already introduced that will help foster a more transparen­t marketplac­e in healthcare. For example, the mandate on hospitals to provide clear, accessible pricing informatio­n online about the items and services they provide is a tool desperatel­y needed for patients seeking elective procedures or treatments and are responsibl­e for deductible­s or coinsuranc­e payments.

In addition, states should continue introducin­g legislatio­n mandating transparen­cy and accountabi­lity on the pharmacy benefit managers and insurers. For example, two legislatio­ns that passed in Georgia in 2020, House Bill 946 and House Bill 323 (also known as the Pharmacy Anti-Steering and Transparen­cy Act), create transparen­cy for prescripti­on drug prices and prohibit PBM from profiting off prescripti­ons “steered” to their PBM and insurance affiliates.

It is time for our country to move forward with actionable policies that will help reduce healthcare costs. The ideal most often synonymous with the success of such policies is the principle of transparen­cy.

It is well known that lack of transparen­cy in healthcare has led to massive and inappropri­ate profiteeri­ng ...

 ??  ?? Wayne Winegarden
Wayne Winegarden
 ??  ?? Robert Popovian
Robert Popovian

Newspapers in English

Newspapers from United States